The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California.
| Revenue (TTM) | $4.24B |
| Gross Profit (TTM) | $2.79B |
| EBITDA | $932.00M |
| Operating Margin | 20.80% |
| Return on Equity | 6.84% |
| Return on Assets | 2.74% |
| Revenue/Share (TTM) | $21.69 |
| Book Value | $43.81 |
| Price-to-Book | 1.26 |
| Price-to-Sales (TTM) | 2.49 |
| EV/Revenue | 3.046 |
| EV/EBITDA | 13.79 |
| Quarterly Earnings Growth (YoY) | 357.10% |
| Quarterly Revenue Growth (YoY) | 0.60% |
| Shares Outstanding | $190.16M |
| Float | $188.76M |
| % Insiders | 0.63% |
| % Institutions | 111.93% |
Volatility is currently contracting
NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Cooper Companies, Inc. ("Cooper" or the "Company") (NASDAQ: COO).
The Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye Care The Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye Care
New York, New York--(Newsfile Corp. - September 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of The Cooper Companies, Inc. (NASDAQ: COO) resulting from allegations that CooperCompanies may have issued materially misleading business information to the investing public. SO WHAT: If you purchased CooperCompanies securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
SAN FRANCISCO, Sept. 23, 2026 /PRNewswire/ -- Investors in The Cooper Companies, Inc. (NASDAQ: COO) saw the price of their shares trade down $9.31 (-14.6%) after the company reported Q3 2026 financial results that included revelations of its U.S. channel inventory destocking along with other negative surprises.
NEW YORK, Sept. 21, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of The Cooper Companies, Inc. (NASDAQ: COO) resulting from allegations that CooperCompanies may have issued materially misleading business information to the investing public.
Cooper Companies disclosed that it could no longer achieve previous guidance projections and blamed the proactive destocking of U.S. channel inventory for the entirety of the guidance reduction. Levi & Korsinsky investigates.
Activist investor Jana Partners on Friday urged Cooper Companies to launch an external search for a new CEO and consider asset sales, arguing recent missteps have hurt investor confidence and weighed on the medical device maker's market value.
Calls for Board to Commence Immediate External CEO Search, Appoint New Board Chair and ExploreAsset Sales NEW YORK, Sept. 18, 2026 /PRNewswire/ -- JANA Partners ("JANA") today announced that it has sent a letter to the Board of Directors (the "Board") of The Cooper Companies, Inc. (Nasdaq: COO) ("Cooper" or the "Company") highlighting the companies consistent underperformance and calling on it to take several actions to improve shareholder value including the immediate initiation of an external search for a CEO, the appointment of a new board chair and the evaluation of asset sales.
The medical-device manufacturer requires an urgent overhaul to address its “chronic underperformance,” the activist hedge fund's letter says.
NEW YORK, Sept. 17, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Cooper Companies, Inc. ("Cooper" or the "Company") (NASDAQ: COO).
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on COO and any ticker you trade — then tracks every position and per-strategy win rate.
